InvestorsHub Logo
Followers 163
Posts 12871
Boards Moderated 1
Alias Born 01/26/2016

Re: longfellow95 post# 65346

Thursday, 06/23/2016 7:40:09 PM

Thursday, June 23, 2016 7:40:09 PM

Post# of 698591
longfellow95,

The "gentleman from Roche" that Linda referred to a while back in one of her presentations would be a hint at the nod you refer to. Roche is also heavily over weighted in oncology and would have the most to lose if left out of the new oncology products picture. They need to be part of this type of breakthrough combination technology and their anti PDL-1 is seen as having very good potential, perhaps even best in class.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News